bilastine

North America

Canada (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
BLEXTEN 20MG tabs
Rx
oral
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
BLEXTEN 20MG tabs
02454130
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (0)
No result.

Europe

Austria (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
NASITOP 10 MG orodisp tabs
Rx
-
R06AX29
NASITOP 2,5 MG/ML oral sol
Rx
-
R06AX29
NASITOP 20 MG tabs
OTC
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
NASITOP 10 MG orodisp tabs
137893
15-09-2017
NASITOP 2,5 MG/ML oral sol
137894
15-09-2017
NASITOP 20 MG tabs
1-30199
23-03-2011
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Belgium (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
BELLOZAL 10 MG orodisp tabs
10x
20x
30x
50x
-
-
-
-



oral
R06AX29
BELLOZAL 2,5 MG/ML oral sol
1x, 120 mL
-
oral
R06AX29
BELLOZAL 20 MG tabs
10x
20x
30x
40x
50x
-
-
Y
-
Y




oral
R06AX29
ILEXEL 20 MG tabs
10x
20x
30x
40x
50x
-
-
Y
-
Y




oral
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
BELLOZAL 10 MG orodisp tabs
10x
20x
30x
50x
BE513946
BE513946
BE513946
BE513946
-
-
-
-
BELLOZAL 2,5 MG/ML oral sol
1x, 120 mL
BE513955
-
BELLOZAL 20 MG tabs
10x
20x
30x
40x
50x
BE381211
BE381211
BE381211
BE381211
BE381211
-
-
-
-
-
ILEXEL 20 MG tabs
10x
20x
30x
40x
50x
BE401387
BE401387
BE401387
BE401387
BE401387
-
-
-
-
-
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
BELLOZAL 10 MG orodisp tabs
10x
20x
30x
50x
BELLOZAL 2,5 MG/ML oral sol
1x, 120 mL
BELLOZAL 20 MG tabs
10x
20x
30x
40x
50x
5,52
8,76
ILEXEL 20 MG tabs
10x
20x
30x
40x
50x
5,52
8,76
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
XADOS 10 MG orodisp tabs
10 oralnih disperziblnih tabs (1 Al/Al b
Rx
-
R06AX29
XADOS 2,5 MG/ML oral sol
1 bottle sa 120 ml oralne otopine
Rx
-
R06AX29
XADOS 20 MG tabs
10 tabs (1 PA/PVC/Alblister)
Rx
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
XADOS 10 MG orodisp tabs
10 oralnih disperziblnih tabs (1 Al/Al b
BIH-H-4167911-5
-
30-04-2020
29-04-2025
XADOS 2,5 MG/ML oral sol
1 bottle sa 120 ml oralne otopine
BIH-H-2942894-4
-
23-06-2020
22-06-2025
XADOS 20 MG tabs
10 tabs (1 PA/PVC/Alblister)
BIH-H-3120111-2
-
22-11-2017
21-11-2022
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Croatia (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
NIXAR 20 MG tabs
10 tabs in blister
20 tabs in blister
Y
Y
Rx
Rx
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
NIXAR 20 MG tabs
10 tabs in blister
20 tabs in blister
HR-H-535007756-01
HR-H-535007756-02
12-01-2018
12-01-2018
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Czechia (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
XADOS 10MG orodisp tabs
10MG 10
10MG 20
10MG 30
10MG 50
N
N
Y
N
oral
R06AX29
XADOS 2,5MG/ML oral sol
2,5MG/ML 120ML I
2,5MG/ML 120ML II
N
Y
oral
R06AX29
XADOS 20MG tabs
20MG 10
20MG 20
20MG 30
20MG 40
20MG 50
N
N
Y
N
Y
oral
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
XADOS 10MG orodisp tabs
10MG 10
10MG 20
10MG 30
10MG 50
24/ 750/15-C
24/ 750/15-C
24/ 750/15-C
24/ 750/15-C
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
XADOS 2,5MG/ML oral sol
2,5MG/ML 120ML I
2,5MG/ML 120ML II
24/ 751/15-C
24/ 751/15-C
MRP/DCP
MRP/DCP
XADOS 20MG tabs
20MG 10
20MG 20
20MG 30
20MG 40
20MG 50
24/ 001/11-C
24/ 001/11-C
24/ 001/11-C
24/ 001/11-C
24/ 001/11-C
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
XADOS 10MG orodisp tabs
10MG 10
10MG 20
10MG 30
10MG 50
0
0
179,93
0
269,84
XADOS 2,5MG/ML oral sol
2,5MG/ML 120ML I
2,5MG/ML 120ML II
0
160,68
241,67
XADOS 20MG tabs
20MG 10
20MG 20
20MG 30
20MG 40
20MG 50
0
0
140,77
0
259,78
212,14
386,66
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Denmark (6)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
BILASKA 20 MG tabs
-
-
R06AX29
BILASTIN 2CARE4 20 MG tabs
-
-
R06AX29
BILASTIN PARANOVA 20 MG tabs
-
-
R06AX29
REVITELLE 10 MG orodisp tabs
-
-
R06AX29
REVITELLE 2,5 MG/ML oral sol
-
-
R06AX29
REVITELLE 20 MG tabs
-
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
BILASKA 20 MG tabs
28105479814
PI
26-09-2014
BILASTIN 2CARE4 20 MG tabs
28106023117
PI
19-01-2018
BILASTIN PARANOVA 20 MG tabs
28106023817
PI
08-01-2018
REVITELLE 10 MG orodisp tabs
28105680715
DCP
19-09-2017
REVITELLE 2,5 MG/ML oral sol
28105680815
DCP
19-09-2017
REVITELLE 20 MG tabs
28104481909
DCP
28-10-2010
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
BILASKA 20 MG tabs
BILASTIN 2CARE4 20 MG tabs
BILASTIN PARANOVA 20 MG tabs
REVITELLE 10 MG orodisp tabs
REVITELLE 2,5 MG/ML oral sol
REVITELLE 20 MG tabs
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Finland (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
REVITELLE 10 MG orodisp tabs
10x in blister
20x in blister
30x in blister
50x in blister
N
N
Y
N
Rx
Rx
Rx
Rx
-
R06AX29
REVITELLE 2.5 MG/ML oral sol
120 ml in bottle
N
Rx
-
R06AX29
REVITELLE 20 MG tabs
10x in blister
20x in blister
30x in blister
40x in blister
50x in blister
N
N
Y
N
N
Rx
Rx
Rx
Rx
Rx
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
REVITELLE 10 MG orodisp tabs
10x in blister
20x in blister
30x in blister
50x in blister
33694
33694
33694
33694
-
-
-
-
24-08-2017
24-08-2017
24-08-2017
24-08-2017
REVITELLE 2.5 MG/ML oral sol
120 ml in bottle
33695
-
01-09-2017
REVITELLE 20 MG tabs
10x in blister
20x in blister
30x in blister
40x in blister
50x in blister
27335
27335
27335
27335
27335
-
-
-
-
-
28-12-2010
28-12-2010
28-12-2010
28-12-2010
28-12-2010
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Hungary (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
LENDIN 10 MG orodisp tabs
10x blister
20x blister
30x blister
50x blister
N
N
Y
N
Rx
Rx
Rx
Rx
-
R06AX29
LENDIN 2,5 MG/ML oral sol
1x120ml glass
Y
Rx
-
R06AX29
LENDIN 20 MG tabs
10x blister
20x blister
30x blister
N
Y
Y
Rx
Rx
Rx
oral
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
LENDIN 10 MG orodisp tabs
10x blister
20x blister
30x blister
50x blister
OGYI-T-21640/04
OGYI-T-21640/05
OGYI-T-21640/06
OGYI-T-21640/07
26-07-2017
26-07-2017
26-07-2017
26-07-2017
LENDIN 2,5 MG/ML oral sol
1x120ml glass
OGYI-T-21640/08
26-07-2017
LENDIN 20 MG tabs
10x blister
20x blister
30x blister
OGYI-T-21640/01
OGYI-T-21640/02
OGYI-T-21640/03
24-02-2011
24-02-2011
24-02-2011
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
LENDIN 10 MG orodisp tabs
10x blister
20x blister
30x blister
50x blister
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
LENDIN 2,5 MG/ML oral sol
1x120ml glass
0
0
0
0
LENDIN 20 MG tabs
10x blister
20x blister
30x blister
0
0
0
0
0
0
0
0
0
0
0
0
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Iceland (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
BILAXTEN 10 MG orodisp tabs
N
Rx
-
R06AX29
BILAXTEN 2,5 MG/ML oral sol
N
Rx
-
R06AX29
BILAXTEN 20 MG tabs
N
Rx
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
BILAXTEN 10 MG orodisp tabs
11-07-2017
BILAXTEN 2,5 MG/ML oral sol
11-07-2017
BILAXTEN 20 MG tabs
23-09-2010
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
BILAXTEN 10 MG orodisp tabs
BILAXTEN 2,5 MG/ML oral sol
BILAXTEN 20 MG tabs
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Ireland (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
DRYNOL 10 MG orodisp tabs
Y
Rx
oral
R06AX29
DRYNOL 2.5 MG/ML oral sol
Y
Rx
oral
R06AX29
DRYNOL 20 MG tabs
Y
Rx
oral
R06AX29
DRYNOL 20MG 20 MG tabs
-
Rx
oral
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
DRYNOL 10 MG orodisp tabs
PA0865/018/002
14-07-2017
DRYNOL 2.5 MG/ML oral sol
PA0865/018/003
14-07-2017
DRYNOL 20 MG tabs
PA0865/018/001
18-02-2011
DRYNOL 20MG 20 MG tabs
PPA0465/424/001
01-03-2017
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
OPEXA 10 MG orodisp tabs
N10 blister
N20 blister
N30 blister
N50 blister
Rx
Rx
Rx
Rx
oral
R06AX29
OPEXA 2,5 MG/ML oral sol
120 ml ir taurelė N1 bottle
Rx
oral
R06AX29
OPEXA 20 MG tabs
N10 blister
N30 blister
Rx
Rx
oral
R06AX29
OPEXA 20 MG tabs
N10 blister
N20 blister
N30 blister
N40 blister
N50 blister
Rx
Rx
Rx
Rx
Rx
oral
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
OPEXA 10 MG orodisp tabs
N10 blister
N20 blister
N30 blister
N50 blister
LT/1/10/2241/006
LT/1/10/2241/007
LT/1/10/2241/008
LT/1/10/2241/009
DCP
DCP
DCP
DCP
27-07-2017
27-07-2017
27-07-2017
27-07-2017
OPEXA 2,5 MG/ML oral sol
120 ml ir taurelė N1 bottle
LT/1/10/2241/010
DCP
27-07-2017
OPEXA 20 MG tabs
N10 blister
N30 blister
LT/L/20/1353/001
LT/L/20/1353/002
PI
PI
30-07-2020
30-07-2020
OPEXA 20 MG tabs
N10 blister
N20 blister
N30 blister
N40 blister
N50 blister
LT/1/10/2241/001
LT/1/10/2241/002
LT/1/10/2241/003
LT/1/10/2241/004
LT/1/10/2241/005
DCP
DCP
DCP
DCP
DCP
24-11-2010
24-11-2010
24-11-2010
24-11-2010
24-11-2010
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Malta (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GOSALL 10MG orodisp tabs
Rx
-
R06AX29
GOSALL 2.5MG/ML oral sol
Rx
-
R06AX29
GOSALL 20MG tabs
Rx
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GOSALL 10MG orodisp tabs
MA204/00502
26-10-2017
GOSALL 2.5MG/ML oral sol
MA204/00503
26-10-2017
GOSALL 20MG tabs
MA204/00501
01-02-2012
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Netherlands (0)
No result.
Norway (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ZILAS 20 MG tabs
10
-
Rx
oral
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ZILAS 20 MG tabs
10
01-03-2014
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Poland (10)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
BILAXTEN 10 MG Tabletki ulegające rozpadowi w jamie ustnej
10 tabs
20 tabs
30 tabs
50 tabs
-
-
-
-
Rx
Rx
Rx
Rx
-
R06AX29
BILAXTEN 2,5 MG/ML oral sol
1 bottle 120 ml
-
Rx
-
R06AX29
BILAXTEN 20 MG tabs
10 tabs
20 tabs
30 tabs
40 tabs
50 tabs
-
-
-
-
-
Rx
Rx
Rx
Rx
Rx
-
R06AX29
CLATRA 10 MG Tabletki ulegające rozpadowi w jamie ustnej
10 tabs
20 tabs
30 tabs
50 tabs
-
-
-
-
Rx
Rx
Rx
Rx
-
R06AX29
CLATRA 2,5 MG/ML oral sol
1 bottle 120 ml
-
Rx
-
R06AX29
CLATRA 20 MG tabs
10 tabs
10 tabs
20 tabs
30 tabs
30 tabs
40 tabs
50 tabs
-
-
-
-
-
-
-
Rx
Rx
Rx
Rx
Rx
Rx
Rx
-
R06AX29
CLATRA 20 MG tabs
10 tabs
10 tabs
10 tabs
10 tabs
20 tabs
20 tabs
20 tabs
30 tabs
30 tabs
30 tabs
30 tabs
40 tabs
40 tabs
40 tabs
50 tabs
50 tabs
50 tabs
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
-
R06AX29
CLATRA 20 MG tabs
10 tabs
20 tabs
30 tabs
40 tabs
50 tabs
-
-
-
-
-
Rx
Rx
Rx
Rx
Rx
-
R06AX29
CLATRA 20 MG tabs
10 tabs
20 tabs
-
-
Rx
Rx
-
R06AX29
CLATRA 20 MG tabs
10 tabs
20 tabs
30 tabs
40 tabs
50 tabs
-
-
-
-
-
Rx
Rx
Rx
Rx
Rx
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
BILAXTEN 10 MG Tabletki ulegające rozpadowi w jamie ustnej
10 tabs
20 tabs
30 tabs
50 tabs
24210
24210
24210
24210
DCP
DCP
DCP
DCP
16-08-2022
16-08-2022
16-08-2022
16-08-2022
BILAXTEN 2,5 MG/ML oral sol
1 bottle 120 ml
24211
DCP
16-08-2022
BILAXTEN 20 MG tabs
10 tabs
20 tabs
30 tabs
40 tabs
50 tabs
17821
17821
17821
17821
17821
DCP
DCP
DCP
DCP
DCP
CLATRA 10 MG Tabletki ulegające rozpadowi w jamie ustnej
10 tabs
20 tabs
30 tabs
50 tabs
24195
24195
24195
24195
DCP
DCP
DCP
DCP
10-08-2022
10-08-2022
10-08-2022
10-08-2022
CLATRA 2,5 MG/ML oral sol
1 bottle 120 ml
24196
DCP
10-08-2022
CLATRA 20 MG tabs
10 tabs
10 tabs
20 tabs
30 tabs
30 tabs
40 tabs
50 tabs
408/17
313/20
408/17
408/17
313/20
408/17
408/17
PI
PI
PI
PI
PI
PI
PI
11-12-2022
04-12-2025
11-12-2022
11-12-2022
04-12-2025
11-12-2022
11-12-2022
CLATRA 20 MG tabs
10 tabs
10 tabs
10 tabs
10 tabs
20 tabs
20 tabs
20 tabs
30 tabs
30 tabs
30 tabs
30 tabs
40 tabs
40 tabs
40 tabs
50 tabs
50 tabs
50 tabs
239/19
36/18
80/21
299/18
239/19
36/18
299/18
239/19
36/18
80/21
299/18
36/18
299/18
239/19
36/18
299/18
239/19
PI
PI
PI
PI
PI
PI
PI
PI
PI
PI
PI
PI
PI
PI
PI
PI
PI
25-06-2024
25-01-2023
04-03-2026
19-10-2023
25-06-2024
25-01-2023
19-10-2023
25-06-2024
25-01-2023
04-03-2026
19-10-2023
25-01-2023
19-10-2023
25-06-2024
25-01-2023
19-10-2023
25-06-2024
CLATRA 20 MG tabs
10 tabs
20 tabs
30 tabs
40 tabs
50 tabs
17820
17820
17820
17820
17820
DCP
DCP
DCP
DCP
DCP
CLATRA 20 MG tabs
10 tabs
20 tabs
333/20
333/20
PI
PI
23-12-2025
23-12-2025
CLATRA 20 MG tabs
10 tabs
20 tabs
30 tabs
40 tabs
50 tabs
239/18
239/18
239/18
239/18
239/18
PI
PI
PI
PI
PI
17-08-2023
17-08-2023
17-08-2023
17-08-2023
17-08-2023
Product
Pack
SPC
PIL
Company
BILAXTEN 10 MG Tabletki ulegające rozpadowi w jamie ustnej
10 tabs
20 tabs
30 tabs
50 tabs
BILAXTEN 2,5 MG/ML oral sol
1 bottle 120 ml
BILAXTEN 20 MG tabs
10 tabs
20 tabs
30 tabs
40 tabs
50 tabs
CLATRA 10 MG Tabletki ulegające rozpadowi w jamie ustnej
10 tabs
20 tabs
30 tabs
50 tabs
CLATRA 2,5 MG/ML oral sol
1 bottle 120 ml
CLATRA 20 MG tabs
10 tabs
10 tabs
20 tabs
30 tabs
30 tabs
40 tabs
50 tabs
CLATRA 20 MG tabs
10 tabs
10 tabs
10 tabs
10 tabs
20 tabs
20 tabs
20 tabs
30 tabs
30 tabs
30 tabs
30 tabs
40 tabs
40 tabs
40 tabs
50 tabs
50 tabs
50 tabs
CLATRA 20 MG tabs
10 tabs
20 tabs
30 tabs
40 tabs
50 tabs
CLATRA 20 MG tabs
10 tabs
20 tabs
CLATRA 20 MG tabs
10 tabs
20 tabs
30 tabs
40 tabs
50 tabs
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
BORENAR 10 MG orodisp tabs
blister x 10 tabs orodispersabile
blister x 20 tabs orodispersabile
blister x 30 tabs orodispersabile
blister x 50 tabs orodispersabile
-
-
-
-
PRF
PRF
PRF
PRF
-
R06AX29
BORENAR 2,5 MG/ML oral sol
1 flac. din sticla bruna, închis cu capa
1 flac. din sticla bruna, închis cu capa
-
-
PRF
PRF
-
R06AX29
BORENAR 20 MG tabs
blister x 30 tabs
blister x 40 tabs
blister x 50 tabs
blister x10 tabs
blisterx 20 tabs
-
-
-
-
-
PRF
PRF
PRF
PRF
PRF
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
BORENAR 10 MG orodisp tabs
blister x 10 tabs orodispersabile
blister x 20 tabs orodispersabile
blister x 30 tabs orodispersabile
blister x 50 tabs orodispersabile
-
-
-
-
BORENAR 2,5 MG/ML oral sol
1 flac. din sticla bruna, închis cu capa
1 flac. din sticla bruna, închis cu capa
-
-
BORENAR 20 MG tabs
blister x 30 tabs
blister x 40 tabs
blister x 50 tabs
blister x10 tabs
blisterx 20 tabs
-
-
-
-
-
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Slovenia (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
BILADOR 10 MG orodisp tabs
20 tabs (2 x 10 tabs blister)
30 tabs (3 x 10 tabs blister)
-
-
Rx
Rx
oral
R06AX29
BILADOR 2,5 MG/ML oral sol
steklenico navojno zaporko zaščito pred
-
Rx
oral
R06AX29
BILADOR 20 MG tabs
10 tabs (1 x 10 tabs blister)
20 tabs (2 x 10 tabs blister)
30 tabs (3 x 10 tabs blister)
40 tabs (4 x 10 tabs blister)
50 tabs (5 x 10 tabs blister)
-
-
N
-
-
Rx
Rx
Rx
Rx
Rx
oral
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
BILADOR 10 MG orodisp tabs
20 tabs (2 x 10 tabs blister)
30 tabs (3 x 10 tabs blister)
1010-85/2015-20
1010-85/2015-20
DCP
DCP
02-11-2017
02-11-2017
02-11-2022
02-11-2022
BILADOR 2,5 MG/ML oral sol
steklenico navojno zaporko zaščito pred
1010-85/2015-20
DCP
02-11-2017
02-11-2022
BILADOR 20 MG tabs
10 tabs (1 x 10 tabs blister)
20 tabs (2 x 10 tabs blister)
30 tabs (3 x 10 tabs blister)
40 tabs (4 x 10 tabs blister)
50 tabs (5 x 10 tabs blister)
1011-131/2014-11
1011-131/2014-11
1011-131/2014-11
1011-131/2014-11
1011-131/2014-11
DCP
DCP
DCP
DCP
DCP
02-06-2016
02-06-2016
02-06-2016
02-06-2016
02-06-2016
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
BILADOR 10 MG orodisp tabs
20 tabs (2 x 10 tabs blister)
30 tabs (3 x 10 tabs blister)
BILADOR 2,5 MG/ML oral sol
steklenico navojno zaporko zaščito pred
BILADOR 20 MG tabs
10 tabs (1 x 10 tabs blister)
20 tabs (2 x 10 tabs blister)
30 tabs (3 x 10 tabs blister)
40 tabs (4 x 10 tabs blister)
50 tabs (5 x 10 tabs blister)
5,42
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Spain (10)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
BILAXTEN 10 MG orodisp tabs
20 tabs
Y
Rx
oral
R06AX29
BILAXTEN 2,5 MG/ML oral sol
1 bottle of 120 ml
Y
Rx
oral
R06AX29
BILAXTEN 20 MG tabs
20 tabs
Y
Rx
oral
R06AX29
BILAXTEN 20 MG tabs
20 tabs
20 tabs
20 tabs
20 tabs
Y
Y
Y
Y
Rx
Rx
Rx
Rx
oral
R06AX29
BILAXTEN 20 MG tabs
20 tabs
Y
Rx
oral
R06AX29
IBIS 10 MG orodisp tabs
20 tabs
Y
Rx
oral
R06AX29
IBIS 2,5 MG/ML oral sol
1 bottle of 120 ml
Y
Rx
oral
R06AX29
IBIS 20 MG tabs
20 tabs
20 tabs
20 tabs
20 tabs
Y
Y
Y
Y
Rx
Rx
Rx
Rx
oral
R06AX29
IBIS 20MG tabs
20 tabs
20 tabs
Y
Y
Rx
Rx
oral
R06AX29
OBALIX 20 MG tabs
20 tabs
-
Rx
oral
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
BILAXTEN 10 MG orodisp tabs
20 tabs
82581
07-11-2017
BILAXTEN 2,5 MG/ML oral sol
1 bottle of 120 ml
82582
07-11-2017
BILAXTEN 20 MG tabs
20 tabs
73027
18-11-2010
BILAXTEN 20 MG tabs
20 tabs
20 tabs
20 tabs
20 tabs
34009 499 140 1 2 IP
34009 499 140 1 2 IP2
3400949914012
34009 499 140 1 2 IP1
08-11-2018
24-07-2020
02-08-2016
25-02-2020
BILAXTEN 20 MG tabs
20 tabs
5341508
06-09-2018
IBIS 10 MG orodisp tabs
20 tabs
82661
26-01-2018
IBIS 2,5 MG/ML oral sol
1 bottle of 120 ml
82660
26-01-2018
IBIS 20 MG tabs
20 tabs
20 tabs
20 tabs
20 tabs
65925723
73029
2400111-C
65925723IP
08-11-2018
18-11-2010
03-08-2016
21-02-2019
IBIS 20MG tabs
20 tabs
20 tabs
499136-4IP
499136-4
16-02-2015
15-09-2014
OBALIX 20 MG tabs
20 tabs
73028
18-11-2010
Product
Pack
SPC
PIL
Company
BILAXTEN 10 MG orodisp tabs
20 tabs
BILAXTEN 2,5 MG/ML oral sol
1 bottle of 120 ml
BILAXTEN 20 MG tabs
20 tabs
BILAXTEN 20 MG tabs
20 tabs
20 tabs
20 tabs
20 tabs
BILAXTEN 20 MG tabs
20 tabs
IBIS 10 MG orodisp tabs
20 tabs
IBIS 2,5 MG/ML oral sol
1 bottle of 120 ml
IBIS 20 MG tabs
20 tabs
20 tabs
20 tabs
20 tabs
IBIS 20MG tabs
20 tabs
20 tabs
OBALIX 20 MG tabs
20 tabs
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
BILASSA 20 MG tabs
Rx
-
R06AX29
BILAXTEN 10 MG orodisp tabs
Rx
-
R06AX29
BILAXTEN 2,5 MG/ML oral sol
Rx
-
R06AX29
BILAXTEN 20 MG tabs
Rx
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
BILASSA 20 MG tabs
Nationell decentral eller ömsesidig
15-04-2021
BILAXTEN 10 MG orodisp tabs
Nationell decentral eller ömsesidig
24-08-2017
BILAXTEN 2,5 MG/ML oral sol
Nationell decentral eller ömsesidig
24-08-2017
BILAXTEN 20 MG tabs
Nationell decentral eller ömsesidig
15-10-2010
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Switzerland (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
BILAXTEN 20 MG tabs
-
-
-
-
-
B
B
B
B
B
-
R06AX29
BILAXTEN KIDS orodisp tabs
-
-
-
-
B
B
B
B
-
R06AX29
BILAXTEN KIDS Lösung zum Einnehmen
-
B
-
R06AX29
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
BILAXTEN 20 MG tabs
61446 1
61446 1
61446 1
61446 1
61446 1
Hauptzulassung
Hauptzulassung
Hauptzulassung
Hauptzulassung
Hauptzulassung
31-10-2011
31-10-2011
31-10-2011
31-10-2011
31-10-2011
30-10-2021
30-10-2021
30-10-2021
30-10-2021
30-10-2021
BILAXTEN KIDS orodisp tabs
66713 1
66713 1
66713 1
66713 1
Hauptzulassung
Hauptzulassung
Hauptzulassung
Hauptzulassung
31-01-2019
31-01-2019
31-01-2019
31-01-2019
30-01-2024
30-01-2024
30-01-2024
30-01-2024
BILAXTEN KIDS Lösung zum Einnehmen
66712 1
Hauptzulassung
31-01-2019
30-01-2024
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.